Modulation of 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells by K(ATP)...

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• 1-methyl-4-phenylpyridinium (MPP(+)) is a neurotoxin that induces cell death.
• Mitochondrial K(ATP) channels play a role in cellular responses to toxins.
• PC12 cells are a commonly used model for neuronal studies.

Purpose of the Study:

• To investigate the protective effect of 5-hydroxydecanoate, a mitochondrial K(ATP) channel blocker, against MPP(+)-induced cytotoxicity in PC12 cells.
• To elucidate the mechanisms underlying this protective effect.

Main Methods:

• Differentiated PC12 cells were treated with MPP(+) and/or 5-hydroxydecanoate.
• Cell viability, GSH levels, nuclear damage, mitochondrial membrane potential, and reactive oxygen species (ROS) production were assessed.
• Inhibitory effects of 5-hydroxydecanoate and glibenclamide were evaluated.

Main Results:

• 5-hydroxydecanoate and glibenclamide significantly reduced MPP(+)-induced cell death and GSH depletion.
• 5-hydroxydecanoate attenuated MPP(+)-induced nuclear damage, mitochondrial permeability changes, and ROS formation.
• The protective effect involved suppression of mitochondrial permeability transition, cytochrome c release, and caspase-3 activation.

Conclusions:

• 5-hydroxydecanoate protects PC12 cells from MPP(+)-induced neurotoxicity.
• This protection is mediated by blocking mitochondrial K(ATP) channels, which inhibits mitochondrial dysfunction, ROS production, and GSH depletion.
• Targeting mitochondrial K(ATP) channels may be a therapeutic strategy against MPP(+)-induced neuronal damage.